Transplant Surgery Practice Questions

Q: What is the most common indication for liver transplantation in end-stage liver disease?

Chronic hepatitis C. **Explanation:** The most common indication for liver transplantation (LT) globally, and historically the leading cause of end-stage liver disease (ESLD) requiring transplant, is **Chronic Hepatitis C (HCV)**. While the advent of highly effective Direct-Acting Antivirals (DAAs) is changing the landscape, HCV-related cirrhosis and its complication, Hepatocellular Carcinoma (HCC), remain the top reasons for LT in most international registries. **Analysis of Options:** * **Chronic Hepatitis C (Correct):** It is the leading cause of cirrhosis and HCC worldwide. Even with curative antiviral therapy, patients with established cirrhosis remain at risk for decompensation and malignancy, necessitating transplantation. * **Alcoholic Liver Injury (Incorrect):** This is the **second most common** indication globally. In some specific Western regions, it is currently surpassing HCV due to better viral management, but HCV remains the standard answer for exams based on cumulative data. * **Chronic Hepatitis B (Incorrect):** While a major cause of cirrhosis in Asia and Africa, the availability of effective suppressive therapy (like Tenofovir) and widespread vaccination has made it a less frequent indication for transplant compared to HCV. * **Wilson’s Disease (Incorrect):** This is a common **metabolic** cause for transplant, especially in the pediatric population or young adults presenting with fulminant hepatic failure, but it is rare compared to viral and alcoholic etiologies. **High-Yield Clinical Pearls for NEET-PG:** * **Most common indication in children:** Biliary Atresia. * **Most common indication for "Acute Liver Failure":** Acetaminophen (Paracetamol) toxicity. * **Emerging Trend:** Non-Alcoholic Steatohepatitis (NASH/NAFLD) is the fastest-growing indication for liver transplant worldwide. * **MELD Score:** Used to prioritize patients on the transplant waiting list (based on Bilirubin, Creatinine, and INR).

Q: All are common opportunistic infections seen early in renal transplant recipients, EXCEPT:

Nocardia. In renal transplantation, opportunistic infections follow a predictable chronological pattern based on the level of immunosuppression. This timeline is a high-yield concept for NEET-PG. ### **Why Nocardia is the Correct Answer** Post-transplant infections are typically divided into three periods: 1. **Early (0–1 month):** Infections are usually related to surgical complications or donor/recipient-derived pathogens (e.g., UTI, wound infections, Candidiasis). 2. **Intermediate (1–6 months):** Peak immunosuppression leads to viral activations (CMV, EBV, Herpes) and opportunistic pathogens like *Pneumocystis jirovecii*. 3. **Late (>6 months):** Community-acquired infections or chronic opportunistic infections. **Nocardia** is typically a **late-onset** opportunistic infection, usually occurring **after 6 months** (often between 6–12 months) post-transplant. It presents as pulmonary cavitation, skin abscesses, or CNS involvement. ### **Analysis of Incorrect Options** * **Urinary Tract Infections (C):** These are the **most common** infections in the early period (0–1 month) due to surgical manipulation, stents, and catheters. * **Oral Candidiasis (B):** Fungal infections like Thrush are common in the first month due to high-dose induction steroids. * **Herpes Virus (A):** HSV-1 and HSV-2 reactivation typically occurs early (within the first month) due to the surgical stress and initiation of immunosuppression. ### **High-Yield Clinical Pearls** * **Most common infection overall:** Urinary Tract Infection (UTI). * **Most common viral infection (1–6 months):** Cytomegalovirus (CMV). * **Prophylaxis:** Trimethoprim-sulfamethoxazole (TMP-SMX) is used to prevent *Pneumocystis jirovecii*, but it also provides partial prophylaxis against *Nocardia* and *Toxoplasma*. * **Nocardia Triad:** Pneumonia, brain abscess, and cutaneous lesions in an immunocompromised host.

Q: Which of the following is an absolute contraindication for renal transplant?

Untreated malignancy. **Explanation:** Renal transplantation requires lifelong potent immunosuppression to prevent graft rejection. The presence of an **untreated malignancy** is an absolute contraindication because immunosuppressive drugs inhibit the body’s immune surveillance, leading to rapid tumor progression, metastasis, and significantly increased mortality. Most guidelines require a "waiting period" (cancer-free interval) of 2 to 5 years (depending on the tumor type) before a patient can be considered for a transplant. **Analysis of Incorrect Options:** * **Age >65 years:** Advanced age is a **relative contraindication**. While elderly patients have higher surgical risks, "physiological age" is more important than chronological age. Many centers successfully transplant patients over 70 if they have a reasonable life expectancy and low cardiac risk. * **HIV Infection:** Previously an absolute contraindication, it is now a **relative contraindication**. HIV-positive patients can undergo transplantation if they have a stable CD4 count (>200 cells/µL), undetectable viral load, and no active opportunistic infections. * **Chronic Hepatitis B or C:** These are **relative contraindications**. With the advent of highly effective Direct-Acting Antivirals (DAAs) for Hep C and nucleoside analogs for Hep B, these patients can be safely transplanted and managed post-operatively. **High-Yield Clinical Pearls for NEET-PG:** * **Absolute Contraindications:** Active infection, untreated malignancy, active substance abuse, severe uncorrectable cardiac/pulmonary disease, and non-compliance. * **Most common cause of death** after renal transplant: Cardiovascular disease. * **Most common opportunistic infection** post-transplant: CMV (Cytomegalovirus). * **Hyperacute rejection** is Type II hypersensitivity (pre-formed antibodies); **Acute rejection** is primarily Type IV (T-cell mediated).

Q: What is a long-term complication in a liver recipient?

Hypertension. **Explanation:** The long-term management of liver transplant recipients is dominated by the side effects of chronic immunosuppression. **Hypertension** is a very common long-term complication, occurring in approximately 50–70% of patients. **Why Hypertension is the Correct Answer:** The primary cause is the use of **Calcineurin Inhibitors (CNIs)**, such as **Cyclosporine** and **Tacrolimus**, which are the backbone of post-transplant immunosuppression. These drugs cause systemic vasoconstriction (especially of the afferent glomerular arterioles) and sodium retention, leading to secondary hypertension. Chronic corticosteroid use also contributes to elevated blood pressure through mineralocorticoid effects. **Analysis of Incorrect Options:** * **A. Amyloid nephropathy:** This is typically associated with chronic inflammatory states (like RA or TB) or plasma cell dyscrasias, not specifically with liver transplantation. * **C. Pyelonephritis:** While transplant recipients are at risk for infections, pyelonephritis is an acute or recurrent infectious complication rather than a systemic "long-term complication" inherent to the transplant process itself. * **D. Renal cell carcinoma:** While transplant patients have an increased risk of malignancies (especially Skin Cancer and Post-Transplant Lymphoproliferative Disorder/PTLD), RCC is not a classic or common long-term complication specific to liver recipients. **High-Yield NEET-PG Pearls:** * **Metabolic Syndrome:** Post-transplant patients frequently develop the "Metabolic Quartet": Hypertension, Diabetes Mellitus (PTDM), Hyperlipidemia, and Obesity. * **Nephrotoxicity:** CNIs are the leading cause of chronic kidney disease (CKD) in non-renal transplant recipients. * **Most common cause of late death:** Cardiovascular disease (driven by hypertension and metabolic syndrome) and de novo malignancies.

Q: What is the most common indication for liver transplant in children?

Biliary atresia. **Explanation:** **Biliary Atresia** is the most common indication for liver transplantation in the pediatric population, accounting for approximately **50% of all pediatric transplants**. It is an idiopathic obstructive cholangiopathy characterized by the progressive destruction of the extrahepatic biliary tree, leading to neonatal cholestasis and secondary biliary cirrhosis. While the **Kasai procedure** (hepatoportoenterostomy) is the initial surgical treatment of choice, many children eventually develop progressive liver failure or portal hypertension, necessitating a transplant. **Analysis of Incorrect Options:** * **Viral hepatic disease:** While a common indication in adults (e.g., Hepatitis C or B), it is rare in children due to the success of vaccination programs and the time required for chronic viral infections to progress to cirrhosis. * **Primary sclerosing cholangitis (PSC):** This is a common indication in adults (often associated with Ulcerative Colitis) but is significantly less common in the pediatric age group. * **Crigler-Najjar syndrome (Type 1):** This is a metabolic indication for liver transplant (due to UDP-glucuronosyltransferase deficiency). While it is a classic "textbook" indication for transplant in children to prevent kernicterus, it is statistically much rarer than biliary atresia. **High-Yield Clinical Pearls for NEET-PG:** * **Adults:** The most common indication for liver transplant worldwide is **Hepatocellular Carcinoma (HCC)** or **Cirrhosis** (Alcoholic/NASH). * **Kasai Procedure:** Best outcomes are achieved if performed before **60 days of life**. * **Split Liver Transplant:** This technique is frequently used in pediatrics, where a single donor liver (usually the left lateral segment) is given to a child and the remainder to an adult.

Q: What are the long-term complications for live kidney donors?

Hypertension. **Explanation:** The correct answer is **Hypertension**. **1. Why Hypertension is Correct:** Live kidney donation involves a unilateral nephrectomy, which leads to a compensatory increase in the glomerular filtration rate (hyperfiltration) of the remaining kidney. Over the long term, this hyperfiltration, combined with the reduction in total nephron mass, can lead to secondary focal segmental glomerulosclerosis (FSGS) and an increased risk of developing **gestational hypertension** (in female donors) and **systemic hypertension**. While the absolute risk remains low compared to the general population, it is the most documented long-term medical sequela for donors. **2. Why Incorrect Options are Wrong:** * **HPV Infection:** There is no physiological link between nephrectomy and viral susceptibility. Immunosuppression-related infections (like HPV) are risks for the **recipient**, not the donor. * **Renal Carcinoma:** Studies have shown that the risk of Renal Cell Carcinoma (RCC) in the remaining kidney of a donor is not higher than that of the age-matched general population. * **Pyelonephritis:** While a donor has only one kidney, the anatomical integrity of the urinary tract remains intact. There is no increased predisposition to ascending urinary tract infections or pyelonephritis post-donation. **3. Clinical Pearls for NEET-PG:** * **Mortality:** The perioperative mortality rate for live donors is approximately **0.03%** (very low). * **ESRD Risk:** The risk of End-Stage Renal Disease (ESRD) in donors is slightly higher than in healthy non-donors but lower than in the general population (due to the "healthy donor effect"). * **Follow-up:** Donors require lifelong monitoring of blood pressure and proteinuria. * **Proteinuria:** Mild albuminuria is a common long-term finding due to compensatory hyperfiltration.

Q: Transplantation of an organ at a site other than its original location is called?

Heterotopic graft. ### Explanation **1. Understanding the Correct Answer: Heterotopic Graft** The term **Heterotopic** is derived from the Greek words *heteros* (different) and *topos* (place). In transplant surgery, a heterotopic graft refers to the placement of a donor organ into a recipient at an anatomical site different from its original physiological position. * **Classic Example:** **Renal Transplantation.** The donor kidney is typically placed in the **iliac fossa** (extraperitoneal), while the native kidneys are left in the retroperitoneal lumbar region. **2. Analysis of Incorrect Options** * **A. Orthotopic graft:** This involves placing the donor organ in the **same anatomical position** as the original organ. This usually requires the removal of the recipient's diseased organ. * *Example:* **Liver and Heart transplants** are almost always orthotopic. * **B. Allograft:** This term refers to the **genetic relationship** between donor and recipient, not the location. An allograft is a transplant between two genetically different individuals of the same species (e.g., human to human). * **C. Isograft (Syngeneic graft):** This is a transplant between **genetically identical** individuals, such as monozygotic (identical) twins. **3. NEET-PG High-Yield Clinical Pearls** * **Xenograft:** A transplant between different species (e.g., Pig heart valve to human). * **Autograft:** Tissue moved from one site to another within the same individual (e.g., SSG skin graft or CABG using the saphenous vein). * **Auxiliary Transplantation:** A type of heterotopic transplant where the recipient's native organ is left in place (often used in experimental liver transplants to provide temporary support). * **Most common site for Kidney Transplant:** Right iliac fossa (due to the superficial and horizontal orientation of the iliac vein).

Q: Following renal transplantation, which immunosuppressive drug is primarily administered?

Cyclosporine. **Explanation:** The cornerstone of post-renal transplant management is the prevention of graft rejection through T-cell inhibition. **Cyclosporine** is a Calcineurin Inhibitor (CNI) that revolutionized transplant surgery. It works by binding to cyclophilin, inhibiting calcineurin, and subsequently preventing the transcription of Interleukin-2 (IL-2). Since IL-2 is the primary cytokine responsible for T-lymphocyte activation and proliferation, Cyclosporine effectively prevents host-versus-graft rejection. **Analysis of Options:** * **Cyclophosphamide (A):** An alkylating agent primarily used in chemotherapy and for certain autoimmune conditions (like Wegener's). It is not a first-line maintenance drug for solid organ transplants due to its significant bone marrow toxicity and risk of hemorrhagic cystitis. * **Corticosteroids (B):** While used in "triple therapy" regimens, they are considered adjuncts rather than the primary specific immunosuppressant. They are more commonly used in high doses to treat *acute* rejection episodes. * **Interferon (C):** These are cytokines used to *stimulate* the immune system (e.g., in Hepatitis B/C or certain malignancies). Administering interferon would likely trigger graft rejection. **High-Yield Clinical Pearls for NEET-PG:** * **Standard Triple Therapy:** Most centers use a combination of a CNI (Cyclosporine or Tacrolimus), an antimetabolite (Mycophenolate Mofetil), and Corticosteroids. * **Tacrolimus vs. Cyclosporine:** Tacrolimus is now often preferred over Cyclosporine as it is more potent and has a lower risk of cosmetic side effects. * **Cyclosporine Side Effects:** Remember the "G's and H's": **G**ingival hyperplasia, **G**out, **H**irsutism, **H**ypertension, **H**yperlipidemia, and Nephrotoxicity. * **Monitoring:** Cyclosporine requires therapeutic drug monitoring (TDM) due to its narrow therapeutic index.

Question 1

What is the most common indication for liver transplantation in end-stage liver disease?

Accepted Answer

Chronic hepatitis C

Answer

Wilson's disease

Answer

Chronic hepatitis B

Answer

Alcoholic liver injury

Question 2

What describes a reduced liver transplant?

Accepted Answer

A part of a liver segment transplanted into a recipient depending upon the requirement.

Answer

Given to two recipients after dividing into two parts.

Answer

Left lateral lobe divided and given to a child.

Answer

Left lateral segment divided from segment 2 and given to a child.

Question 3

All are common opportunistic infections seen early in renal transplant recipients, EXCEPT:

Accepted Answer

Nocardia

Answer

Herpes virus

Answer

Oral candidiasis

Answer

Urinary tract infections

Question 4

Which of the following is an absolute contraindication for renal transplant?

Accepted Answer

Untreated malignancy

Answer

Age >65 years

Answer

HIV infection

Answer

Chronic hepatitis B or C

Question 5

What is a long-term complication in a liver recipient?

Accepted Answer

Hypertension

Answer

Amyloid nephropathy

Answer

Pyelonephritis

Answer

Renal cell carcinoma

Question 6

What is the most common indication for liver transplant in children?

Accepted Answer

Biliary atresia

Answer

Viral hepatic disease

Answer

Primary sclerosing cholangitis

Answer

Crigler-Najjar syndrome

Question 7

What are the long-term complications for live kidney donors?

Accepted Answer

Hypertension

Answer

HPV Infection

Answer

Renal Carcinoma

Answer

Pyelonephritis

Question 8

Transplantation of an organ at a site other than its original location is called?

Accepted Answer

Heterotopic graft

Answer

Orthotopic graft

Answer

Allograft

Answer

Isograft

Question 9

Which of the following statements regarding preservatives used in University of Wisconsin solution during organ transplantation is FALSE?

Accepted Answer

Glutathione acts as a free radical scavenger.

Answer

Lactobionate minimizes cell swelling and reperfusion injury.

Answer

Allopurinol is an antioxidant.

Answer

Adenosine is a precursor of energy metabolism.

Question 10

Following renal transplantation, which immunosuppressive drug is primarily administered?

Accepted Answer

Cyclosporine

Answer

Cyclophosphamide

Answer

Corticosteroids

Answer

Interferon

Transplant Surgery — MCQs

Transplant Surgery — MCQs

On this page

Practice by Chapter

Want unlimited practice?